Skip to main content
Izidore Lossos, MD, Hematology, Miami, FL, Jackson Health System

IzidoreLossosMD

Hematology • Miami, FL

Professor of Hematology & Oncology, University Miami School of Medicine

Join to view full profile

Dr. Lossos is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Lossos' full profile

Already have an account?

Education & Training

  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityFellowship, Hematology and Medical Oncology, 1998 - 2001
  • The Hebrew University of Jerusalem Hadassah Medical School
    The Hebrew University of Jerusalem Hadassah Medical SchoolClass of 1987

Certifications & Licensure

  • OR State Medical License
    OR State Medical License 2002 - Present
  • FL State Medical License
    FL State Medical License 2002 - 2026

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2006-2014
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
  • America's Top Doctors for Cancer Castle Connolly, 2005-2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • The Evaluation and Treatment (Tx) of Burkitt Lymphoma (BL) in the Modern Era: Real World (RW) Outcomes and Prognostication across 26 US Cancer Centers (CC)
    Izidore S. Lossos, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Splenic Marginal Zone Lymphoma: A U.S Population-Based Survival Analysis (1997-2016)
    Izidore S. Lossos, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • R-MACLO-IVAM Is an Effective Regimen to Induce Long Term Remission in Untreated Mantle Cell Lymphoma
    Izidore S. Lossos, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Join now to see all

Lectures

  • Atezolizumab in Combination with Obinutuzumab and Lenalidomide Demonstrates Favorable Activity and Manageable Toxicity in Patients with Relapsed/Refractory Follicular ... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Genetic Analysis of Plasmablastic Lymphomas in HIV (+) Patients Reveals Novel Driver Regulators of the Noncanonical NF-Κb Pathway 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study Reflects the Demographics and Subtypes of Patients Diagnosed with Non-Hodgkin Lymphoma in the United States 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Join now to see all

Press Mentions

  • Sylvester Pursues Landmark Research Presented at International Hematology Conference
    Sylvester Pursues Landmark Research Presented at International Hematology ConferenceJanuary 30th, 2023
  • Sylvester Researchers Gain New Insights into Rare Lymphoma
    Sylvester Researchers Gain New Insights into Rare LymphomaOctober 29th, 2021
  • The Eye of a Survivor
    The Eye of a SurvivorAugust 2nd, 2021
  • Join now to see all

Other Languages

  • Russian, Hebrew, Russian

Hospital Affiliations

Dr. Izidore Lossos, Dr. Izidore Lossos, MD, Dr. I Lossos